Research shows that glutathione administration at the time of immunization reconstitutes suppressed CTL responses when nonprofessional antigen-presenting cells are used at high doses
Weeks 17-24 (Escalation to 1 mg): Second Peak Risk Window The escalation to 1 mg carries a similar early-risk profile to the week 5 escalation
Lpez-Milln A, Sagardoy R, Solanas M, Abada A, Abada J
Longer protocols may produce greater results as more follicle cycles complete
Acta Horticulturae 2021, (1306), 121-134
They may suggest adjusting the dose, slowing the titration schedule, or prescribing anti-nausea medication to help you stay on track with treatment